Trinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB) in a report released on Friday. The brokerage set a “sell” rating on the stock.

Trinity Biotech Price Performance

Shares of Trinity Biotech stock opened at $0.69 on Friday. The business has a fifty day simple moving average of $0.82 and a two-hundred day simple moving average of $1.20. Trinity Biotech has a 1 year low of $0.63 and a 1 year high of $3.55. The company has a market capitalization of $12.40 million, a price-to-earnings ratio of -0.30 and a beta of 1.20.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Trinity Biotech stock. Hunter Associates Investment Management LLC raised its holdings in Trinity Biotech plc (NASDAQ:TRIB) by 5.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 378,590 shares of the company’s stock after acquiring an additional 18,780 shares during the period. Hunter Associates Investment Management LLC’s holdings in Trinity Biotech were worth $334,000 at the end of the most recent quarter. 78.97% of the stock is currently owned by hedge funds and other institutional investors.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.